Zhejiang Huakang Pharmaceutical Co., Ltd. (SHA:605077)

Market Cap	3.04B -41.5%
Revenue (ttm)	4.92B +34.5%
Net Income	93.72M -62.5%
EPS	0.31 -59.9%
Shares Out	299.08M
PE Ratio	32.84
Forward PE	n/a
Dividend	0.50 (4.92%)
Ex-Dividend Date	Jun 17, 2026

Volume	2,897,015
Open	10.26
Previous Close	10.22
Day's Range	10.13 - 10.26
52-Week Range	9.73 - 19.44
Beta	0.69
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 28, 2026

About SHA:605077

Zhejiang Huakang Pharmaceutical Co., Ltd. engages in the research, production, and sale of polyols and starch sugar worldwide. The company offers polyols products such as xylitol, is a polyol that occurs naturally regular sugar raise blood sugar levels; sorbitol, is produced by the catalytic hydrogenation of D-glucose and is available as a free-flowing crystalline powder, and as aqueous solutions; maltitol a bulk sweetener produced from naturally occurring compounds in corn; erythritol, is produced by the enzymatic hydrolysis of starch into glu...

• Industry: Chemicals
• Sector: Materials
• Founded: 2001
• Employees: 2,248
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 605077

Financial Performance

In 2025, SHA:605077's revenue was 4.19 billion, an increase of 49.15% compared to the previous year's 2.81 billion. Earnings were 200.30 million, a decrease of -25.40%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 12, 2026

Data Sources Report a data error